Cue Announces Collaboration With Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. to Accelerate Development of Quantitative HIV Viral Load Test for Resource Poor Settings
SAN DIEGO, CA — (Marketwired) — 02/04/16 — Cue, Inc. today announced a collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, (Janssen) to address a significant global health need for HIV viral load testing using Cue–s Lab-In-A-Box proprietary molecular diagnostics platform. The deal was facilitated by Johnson & Johnson Innovation.Today, access to HIV viral load testing in resource poor settings is limited due to cost, and